India reports 18,645 COVID-19 cases in 24 hours; national recovery rate rises to 96.42%

Total fatalities have reached 1,50,999 with 201 more people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed

Press Trust of India January 10, 2021 12:34:19 IST
India reports 18,645 COVID-19 cases in 24 hours; national recovery rate rises to 96.42%

Representational image. AP

New Delhi: India's COVID-19 caseload rose to 1,04,50,284 with 18,645 infections being reported in a day, while the recoveries have surged to 1,00,75,950, according to the Union Health Ministry's data updated on Sunday.

The death toll reached 1,50,999 with 201 more people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.

The number of people who have recuperated from the disease so far surged to 1,00,75,950, pushing the national COVID-19 recovery rate of 96.42 percent, while the case fatality rate dropped to 1.44 percent.

The COVID-19 active caseload remained below three lakh for the 20th consecutive day.

There are 2,23,335 active coronavirus infections in the country which comprise 2.14 percent of the total caseload, the data stated.

India's COVID-19 tally had crossed the 20 lakh-mark on 7 August, 30 lakh on 23 August, 40 lakh on 5 September and 50 lakh on 16 September. It went past 60 lakh on 28 September, 70 lakh on 11 October, crossed 80 lakh on 29 October, 90 lakh on 20 November and surpassed the one crore-mark on 19 December.

According to the ICMR, 18,10,96,622 samples have been tested so far with 8,43,307 samples being tested on Saturday.

Updated Date:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip
India

Ready for COVID-19 vaccine roll-out within 10 days of approval, says health ministry; Boris Johnson postpones India trip

Union health secretary Rajesh Bhushn also said that the Centre has not banned the export of any vaccines. The country's drugs regulator had on 3 January approved Oxford-Astrazeneca's COVID-19 vaccine, manufactured in India by Serum Institute of India, and Bharat Biotech's Covaxin for restricted emergency use.

Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic
India

Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic

Modi reminded people that two doses of vaccine are very important and asked them to keep wearing masks and maintain social distancing even after receiving the jabs

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers
India

As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers

Centre in response to an RTI filed said that it currently has no proposal to indemnify or exempt vaccine manufacturers from any liability in case of serious side-effects/adverse reactions due to inoculation of their vaccines.